ProstACT GLOBAL Explained | Prostate Cancer Therapy Phase III Clinical Trial
- Forums
- ASX - By Stock
- Understanding Telix
ProstACT GLOBAL Explained | Prostate Cancer Therapy Phase III...
-
- There are more pages in this discussion • 890 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$23.00 |
Change
-0.470(2.00%) |
Mkt cap ! $7.662B |
Open | High | Low | Value | Volume |
$23.25 | $23.36 | $22.78 | $20.59M | 895.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 591 | $22.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$23.01 | 661 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 599 | 22.990 |
12 | 1540 | 22.980 |
14 | 1771 | 22.970 |
11 | 1176 | 22.960 |
5 | 678 | 22.950 |
Price($) | Vol. | No. |
---|---|---|
23.000 | 1447 | 8 |
23.010 | 643 | 3 |
23.020 | 1559 | 8 |
23.030 | 1806 | 10 |
23.040 | 903 | 5 |
Last trade - 15.58pm 13/11/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online